|
Market Closed -
Xetra
11:35:32 2026-10-09 EDT
|
5-day change | 1st Jan Change | ||
| 4.660 EUR | +0.87% |
|
-2.10% | -19.66% |
| 09-17 | Novo, Orbis sign up to $1.4 billion deal to develop oral drugs | RE |
| 08-19 | ORBIS AG Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
Company Valuation: ORBIS AG
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|
| Market Cap 1 | 72.44 | 65.34 | 53.98 | 54.45 | 54.92 | 43.75 | - |
| Change | - | -9.8% | -17.39% | 0.88% | 0.87% | -20.34% | - |
| Enterprise Value (EV) | 72.44 | 65.34 | 53.98 | 54.45 | 54.92 | 43.75 | 43.75 |
| Change | - | -9.8% | -17.39% | 0.88% | 0.87% | -20.34% | 0% |
| P/E | 30.6x | 27.4x | 19.9x | 13.6x | 17x | 10.4x | 8.63x |
| PBR | - | - | - | - | - | - | - |
| PEG | - | 34.25x | 1.5x | 0.3x | -0.9x | 0.3x | 0.4x |
| Capitalization / Revenue | 0.74x | 0.54x | 0.41x | 0.41x | 0.41x | 0.32x | 0.3x |
| EV / Revenue | 0x | 0x | 0x | 0x | 0x | 0.32x | 0.3x |
| EV / EBITDA | 0x | 0x | 0x | 0x | 0x | 3.68x | 3.34x |
| EV / EBIT | 0x | 0x | 0x | 0x | 0x | 6.84x | 5.76x |
| EV / FCF | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - |
| Dividend per Share 2 | 0.2 | 0.15 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
| Rate of return | 2.61% | 2.17% | 1.75% | 1.74% | 1.72% | 2.15% | 2.15% |
| EPS 2 | 0.25 | 0.252 | 0.286 | 0.422 | 0.342 | 0.45 | 0.54 |
| Distribution rate | 80% | 59.5% | 35% | 23.7% | 29.2% | 22.2% | 18.5% |
| Net sales 1 | 98.4 | 120.5 | 132.2 | 132.2 | 134.6 | 138 | 147 |
| EBITDA 1 | 8.576 | 9.597 | 10.86 | 11.12 | 11.37 | 11.9 | 13.1 |
| EBIT 1 | 4.437 | 4.855 | 5.14 | 5.019 | 4.368 | 6.4 | 7.6 |
| Net income 1 | 2.369 | 2.389 | 2.712 | 3.999 | 3.241 | 4.3 | 5.1 |
| Net Debt | - | - | - | - | - | - | - |
| Reference price 2 | 7.650 | 6.900 | 5.700 | 5.750 | 5.800 | 4.660 | 4.660 |
| Nbr of stocks (in thousands) | 9,470 | 9,470 | 9,470 | 9,470 | 9,470 | 9,470 | - |
| Announcement Date | 3/31/22 | 3/31/23 | 3/27/24 | 3/28/25 | 3/26/26 | - | - |
1EUR in Million2EUR
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 10.27x | - | - | 2.16% | 48.99M | |
| 22.25x | 3.65x | 12.74x | 2.99% | 213B | |
| 21.8x | 4.61x | 11.3x | 0.76% | 187B | |
| -589.8x | 41.94x | 172.31x | -.--% | 122B | |
| -135.1x | 18.77x | 103.22x | -.--% | 121B | |
| 15.48x | 1.68x | 8.84x | 3.1% | 124B | |
| 13.54x | 2.43x | 9.28x | 6.02% | 77.55B | |
| 19.99x | 5.31x | 13.03x | 2.81% | 59.65B | |
| -15.96x | 7.07x | 12.03x | -.--% | 44.99B | |
| 23.09x | 1.91x | 12.11x | 1.35% | 45.21B | |
| Average | -61.45x | 9.71x | 39.43x | 1.92% | 99.54B | |
| Weighted average by Cap. | -75.17x | 10.19x | 42.19x | 1.87% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- OBS Stock
- Valuation ORBIS AG
Select your edition
All financial news and data tailored to specific country editions
